European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

A safe DIVA vaccine for African Swine Fever control and eradication

Descripción del proyecto

Una nueva vacuna para la peste porcina africana

La peste porcina africana es una enfermedad infecciosa que resulta devastadora, y generalmente mortal, para los cerdos. No existe ninguna vacuna para combatir este virus. La Unión Europea ha establecido medidas de prevención y control que deben aplicarse cuando se sospeche o confirme la presencia de peste porcina africana, ya sea en explotaciones o en jabalíes salvajes. El proyecto financiado con fondos europeos VACDIVA proporcionará tres vacunas piloto seguras y eficaces para jabalíes y cerdos domésticos que están listas para su autorización. También validará pruebas y desarrollará estrategias de costes-beneficios, vigilancia eficaz y control-vacunación. Se realizarán experimentos de campo en Kenia y Lituania. Se ofrecerán modelos epidemiológicos de escenarios mundiales dentro de una cartera de servicios para ayudar a las autoridades sanitarias animales a controlar y erradicar la enfermedad.

Objetivo

African Swine Fever (ASF) is one of the most important viral diseases affecting swine, with a serious socio-economic impact. It is present in more than 13 countries in Europe (10 in the EU), 28 sub-Saharan African countries, and 2 Asian countries, China and Mongolia. No vaccine is available and recent incursions in Europe and Asia are jeopardizing the pig industry worldwide. Control of ASF is based on early diagnosis and the implementation of strict sanitary measures. However, measures taken by affected countries have not been sufficient to stop spread.
The objective of VACDIVA is to solve the ASF problem in Europe and affected countries through innovation efforts. VACDIVA will provide (1) Three safe and effective pilot vaccines for wild boar and domestic pigs ready for registration; (2) validated companion DIVA tests and 3) cost-benefit and effective surveillance and control-vaccination strategies, with field trials in Lithuania and Kenia. Two world leader companies in vaccine production and ASF diagnostic kits will provide production of the new vaccines and DIVA tests. Epidemiological modelling of worldwide scenarios will be offered in a portfolio of services to help animal health authorities control and eradicate the disease. This project will provide policy makers valuable decision support tools to better prevent and control ASF.
VACDIVA counts with the expertise of two world ASF Reference Laboratories (OIE and FAO), the EU reference laboratory (EURL), six EU national Reference Laboratories (of 6 out of the 10 countries currently affected by ASF) and four prestigious ASF research institutions. Participation of Russian, Chinese and African laboratories will provide useful support, increasing acceptance of the vaccines. Active involvement of pig producers, agricultural associations and International agencies like FAO will enlarge the impact of communication, dissemination and training activities.

Convocatoria de propuestas

H2020-SFS-2018-2020

Consulte otros proyectos de esta convocatoria

Convocatoria de subcontratación

H2020-SFS-2019-1

Régimen de financiación

IA - Innovation action

Coordinador

UNIVERSIDAD COMPLUTENSE DE MADRID
Aportación neta de la UEn
€ 2 834 310,29
Dirección
AVENIDA DE SENECA 2
28040 Madrid
España

Ver en el mapa

Región
Comunidad de Madrid Comunidad de Madrid Madrid
Tipo de actividad
Higher or Secondary Education Establishments
Enlaces
Coste total
€ 2 834 310,29

Participantes (22)